Search Videos and More
Risk of Severe COVID-19 Symptoms Remains Throughout Pregnancy, UTSW Study Finds
A UT Southwestern study of more than 1,300 pregnant women diagnosed with COVID-19 found that just 1 in 10 developed moderate, severe, or critical illness and that COVID-19 symptoms and severity were similar across all trimesters.UTSW Researchers Find No Decrease in Preterm Births With Vaginal Progesterone
Progesterone has been used to prevent recurrent preterm births, but a study finds no benefitThe ART and Science of Targeting Gynecologic Tumors
Adaptive radiation therapy (ART) – a new patient tumor personalized technology – is now available to treat and cure women with cervical cancer and other gynecologic tumors.Managing Pregnancy When Mom Has an Eating Disorder
UT Southwestern’s specialized maternal health team can provide supportive care to increase chances of a healthy pregnancy, and our colleagues in psychiatry who specialize in managing eating disorders play a crucial role in pregnancy care too.UTSW Study Finds New Pain Management Approach Reduced Opioid Use After C-sections
Shift to non-steroidal anti-inflammatory medications from patient-controlled medication pumps also boosted breastfeeding rates.UT Southwestern Study Defines Anemia in Pregnancy Using Uncomplicated U.S. Cases
Maternal anemia has the same definition across the sociodemographic spectrum, according to a UT Southwestern study of a diverse population of uncomplicated patients. The findings, published in PLOS ONE, will help guide both prevention and treatment of maternal anemia, a common cause of complications.Spong Named Chair of Obstetrics and Gynecology
Catherine Spong, M.D., has been named Chair of the Department of Obstetrics and Gynecology, where she has served as Vice Chair since 2018. Dr. Spong is a tenured Professor of Obstetrics and Gynecology and a renowned expert in maternal-fetal medicine.PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients
UT Southwestern is leading research to find ways to extend the benefits of PARP-1 inhibitor maintenance medication to more patients with more forms of ovarian cancer.History of Vaccines Offers Lessons on COVID-19 for Pregnant Women
Emily H. Adhikari, M.D., and Catherine Y. Spong, M.D., describe how the available safety and effectiveness data, basic science of mRNA vaccines, and long history of successful administering of other vaccines in pregnant women